Diaceutics PLC PDMR Shareholding/SIP & Total Voting Rights (8967R)
October 31 2023 - 7:38AM
UK Regulatory
TIDMDXRX
RNS Number : 8967R
Diaceutics PLC
31 October 2023
31 October 2023
Diaceutics PLC
PDMR Shareholding/Share Incentive Plan and Total Voting
Rights
Diaceutics PLC , ( AIM: DXRX), a leading technology and
solutions provider to the pharmaceutical industry, has been
notified that on 27 October 2023, Global Shares Trustees (UK)
Limited (the "UK Trust") and Zedra Trust Company (Guernsey)
Limited, the trustees of the Global Diaceutics plc 2020 Employee
Benefit Trust , have purchased ordinary shares of GBP0.002 in the
capital of the Company ("Shares") on behalf of Susanne Munksted,
Jordan Clark, Julie Browne, Nick Roberts and Jillian Beggs (PDMRs),
in respect of their purchase of Shares pursuant to the Company's UK
and Global Share Incentive Plan ("the SIP Schemes") for employees .
These purchases will be made each month until further notice.
In accordance with the SIP Schemes, the Company has matched
these purchases with a matched share award over an equivalent
number of Shares purchased by the employee, in the proportion of
1:1.
As announced on 2 October 2023, application was made to AIM for
a block listing of 1,500,000 Shares to facilitate the admission of
the Shares to trading following the exercise of options inter alia
under the SIP Schemes. Therefore, the matched share awards for the
UK PDMRs, along with those for all other participants in the UK SIP
Scheme, have been settled by the Company issuing 10,299 Shares on
27 October 2023 to the UK Trust. The Trust will hold these Shares
on behalf of participants until they vest in accordance with the UK
Scheme rules.
Following the issue of Shares on 27 October, Diaceutics has
84,491,926 Shares in issue. This figure may be used by shareholders
in the Company as a denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change in their interest in, the share capital of the Company
under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
Diaceutics PLC Tel: +44 (0)28 9040
6500
Nick Roberts, Chief Financial Officer investorrelations@diaceutics.com
Stifel Nicolaus Europe Limited (Nomad & Broker) Tel: +44 (0)20 7710
7600
Ben Maddison
Nick Harland
Kate Hanshaw
Alma PR Tel: +44(0)20 3405
0205
Caroline Forde diaceutics@almapr.co.uk
Matthew Young
Kinvara Verdon
About Diaceutics
At Diaceutics we believe that every patient should get the
opportunity to receive the right test and the right therapy to
positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with
an end-to-end commercialisation solution for precision medicines
through data analytics, scientific and advisory services enabled by
our platform DXRX - The Diagnostics Network (R)
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
-----------------------------------------------------------------------------------
a. Name Susanne Munksted
--------------------------- ------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Precision Medicine Officer
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
--------------------------- ------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a. Name Diaceutics PLC
--------------------------- ------------------------------------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Global Share
Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ----- ------------ ---------------- ---------------
0.88 p 172
-------------------------------------- ------------ ---------------- ---------------
Conditional share award:
----- ------------------------------ ---------------
Price(s) Volume(s)
----- ------------ ---------------- ---------------
Nil 172
-------------------------------------- ------------ ---------------- ---------------
e. Date of the transaction Share purchase and Conditional share award:
27 October 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase: AIM Market of the London
Stock Exchange
Conditional share award: Off-Market
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Jordan Clark
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Data Officer
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.88 p 170
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
Nil 170
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 October 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase: AIM Market of the London
Stock Exchange
Matched Share Award: Off-Market
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Julie Browne
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Operations Officer
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.88 p 170
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
Nil 170
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 October 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase: AIM Market of the London
Stock Exchange
Matched Share Award: Off-Market
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Nick Roberts
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Finance Officer
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.88 p 170
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
Nil 170
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 October 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase : AIM Market of the London
Stock Exchange
Matched Share Award: Off-Market
--------------------------- ------------------------------------------------------
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- -----------------------------------------------------------------------------------
a. Name Jillian Beggs
------------------------------------------------------
2 Reason for notification
--------------------------- ------------------------------------------------------
a. Position/Status Chief Commercial Officer
--------------------------- ------------------------------------------------------
b. Initial notification/ Initial
Amendment
------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a. Name Diaceutics PLC
---------------------------
b. LEI 213800VEWQBB39ZB8J81
--------------------------- ------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- -----------------------------------------------------------------------------------
a. Description of Ordinary shares of GBP 0.002 each
the financial
instrument, type ISIN: GB00BJQTGV64
of instrument
Identification
Code
--------------------------- ------------------------------------------------------
b. Nature of the Ongoing non-discretionary purchase of Shares
transaction matched by the grant of conditional share
award over Shares under the Diaceutics plc
UK Share Incentive Plan ("SIP")
--------------------------- ------------------------------------------------------
c. Price(s) and volume(s) Share purchase:
--------------------------- ----------------------------- --- ----------
Price(s) Volume(s)
--------------------------- ------------
0.88 p 170
------------ ----------------
Matched share award:
------------------------------
Price(s) Volume(s)
------------
Nil 170
------------ ----------------
e. Date of the transaction Share purchase and Matched Share award:
27 October 2023
--------------------------- ------------------------------------------------------
f. Place of the transaction Share Purchase : AIM Market of the London
Stock Exchange
Matched Share Award: Off-Market
--------------------------- ------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEAAEFDDSDFFA
(END) Dow Jones Newswires
October 31, 2023 08:38 ET (12:38 GMT)
Diaceutics (LSE:DXRX)
Historical Stock Chart
From Apr 2024 to May 2024
Diaceutics (LSE:DXRX)
Historical Stock Chart
From May 2023 to May 2024
